68667-54-9

Basic information

• Product Name: 3-(1-phenylhydrazono-D-erythro-2,3,4-trihydroxybut-1-yl)quinoxalin-2-one
• Synonyms: 3-(1-phenylhydrazono-D-erythro-2,3,4-trihydroxybut-1-yl)quinoxalin-2-one
• CAS NO: 68667-54-9
• Molecular Weight: 354.365
• Mol File: 68667-54-9.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: 3-(1-phenylhydrazono-D-erythro-2,3,4-trihydroxybut-1-yl)quinoxalin-2-one(CAS DataBase Reference)
• NIST Chemistry Reference: 3-(1-phenylhydrazono-D-erythro-2,3,4-trihydroxybut-1-yl)quinoxalin-2-one(68667-54-9)
• EPA Substance Registry System: 3-(1-phenylhydrazono-D-erythro-2,3,4-trihydroxybut-1-yl)quinoxalin-2-one(68667-54-9)

Safety Data

• Hazardous Substances Data: 68667-54-9(Hazardous Substances Data)

Upstream product

• 95-54-5 1,2-diamino-benzene 
• 100-63-0 phenylhydrazine 
• 89-65-6 isoascorbic acid 
• 1222-71-5 3-(D_r-1t_F,2c_F,3r_F,4-tetrahydroxy-but-cat_F-yl)-1H-quinoxalin-2-one 

Downstream Products

• 641629-41-6 1-N-allyl-3-[5-(acetoxymethyl)-1-phenylpyrazol-3-yl]quinoxalin-2-one 
• 641629-40-5 1-N-allyl-3-[5-(hydroxymethyl)-1-phenylpyrazol-3-yl]quinoxalin-2-one 
• 641629-39-2 2-O-allyl-3-[5-(hydroxymethyl)-1-phenylpyrazol-3-yl]quinoxaline 
• 40910-67-6 1-phenyl-1H-pyrazolo<3,4-b>quinoxaline-3-carboxaldehyde 
• 947516-24-7 3-(5-(acetoxymethyl)-1-phenyl-pyrazol-3-yl)-1-(2,3-dihydroxypropyl)-quinoxalin-2-one 
• 947516-23-6 1-(2,3-epoxyprop-1-yl)-3-(5-(acetoxymethyl)-1-phenyl-pyrazol-3-yl)-quinoxalin-2-one 
• 17460-16-1 1-phenyl-3-(D-erythro-trihydroxypropyl)-1H-pyrazolo[3,4-b]quinoxaline 
• 68636-57-7 3-[1-(phenylhydrazono)glyoxal-1-yl]-2-quinoxalinone 
• 66895-45-2 3-<5-(hydroxymethyl)-1-phenylpyrazol-3-yl>quinoxalin-2-one 
• 66895-41-8 3-<5-(Acetoxymethyl)-1-phenylpyrazol-3-yl>quinoxalin-2(1H)-one 

Relevant articles and documents

MAOS of quinoxalines, conjugated pyrazolylquinoxalines and fused pyrazoloquinoxalines from L-ascorbic and D-isoascorbic acid

Microwave-assisted organic synthesis (MAOS) has been used to accelerate the conversion of L-ascorbic acid (1) and D-isoascorbic acid (2) to the title heterocycles by conversion to 3-(L-threo- or D-erythro-glycerol-1-yl) quinoxaline-2-carboxylic acid o-ami